Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
NMS-088 by Nerviano Medical Sciences for Relapsed Acute Myeloid Leukemia: Likelihood of Approval
NMS-088 is under clinical development by Nerviano Medical Sciences and currently in Phase II for Relapsed Acute Myeloid Leukemia. According...
Data Insights
NMS-088 by Nerviano Medical Sciences for Refractory Acute Myeloid Leukemia: Likelihood of Approval
NMS-088 is under clinical development by Nerviano Medical Sciences and currently in Phase II for Refractory Acute Myeloid Leukemia. According...